Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan
Keywords:
COVID-19, SARS, COV-2-Abstract
Coronavirus Disease 2019 (COVID-19), previously called 2019-nCoV, is a novel disease caused by SARS- CoV-2 which was first identified as outbreak of unknown respiratory illness in Wuhan, China. COVID- 19 was declared as global health emergency by WHO on March 11, 2020 and quickly elevated to global pandemic on 11 March 2020. COVID-19 symptom is highly various in each patient, with fever, fatigue, shortness of breath, and cough as the main presenting symptoms. Patient with COVID-19 may shows severe symptom with severe pneumonia and ARDS, mild symptom resembling simple upper respiration tract infection, or even completely asymptomatic. Approximately 80% of cases is mild. However the number may changes as more people are getting tested. Some experts are estimating that up to 50% of all cases may be asymptomatic carrier.References
CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2020 Mar 23]. Available from: https://www.cdc.gov/coronavirus/2019- ncov/hcp/disposition-in-home-patients.html.
Features, evaluation and treatment coronavirus (COVID-19)-StatPearls - NCBI bookshelf [Internet]. [cited 2020 Apr 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/.
Coronavirus Disease 2019 (COVID-19): Practice essentials, background, route of transmission [Internet]. [cited 2020 Apr 3]. Available from: https://emedicine.medscape.com/article/2500114-overview.
Symptoms of Coronavirus | CDC [Internet]. [cited 2020 Apr 3]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
Q&A on coronaviruses (COVID-19) [Internet]. [cited 2020 Apr 3]. Available from: https://www.who.int/news-room/q-a-detail/q-a-coronaviruses.
Chang D, Mo G, Yuan X, et al. Time kinetics of viral clearance and resolution of symptoms in Novel coronavirus infection. Am J Respir Crit Care Med. 2020.
Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020;25(10). Available from: https://www.eurosurveillance.org/content/10.2807/1560- 7917.ES.2020.25.10.2000180.
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of Novel coronavirus–infected pneumonia. N Engl J Med. 2020;382(13):1199–207.
Chen J, Qi T, Liu L, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020 Mar;S0163445320301195.
Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology. 2020 Feb 26;200642.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.